serious medical needs - Oak Leaf Manor

deliberate indifference to serious medical needs

5 min read

Senior Care

Deliberate Indifference To Serious Medical Needs

May 28, 2021 olm0847

Have you experienced having a caregiver or health official neglecting or ignoring your health...

PBGH Calls on New Congress and Administration to Improve Employee Healthcare in 2 Key Areas February 3, 2025

In a new brief, the Purchaser Business Group on Health called for policy changes that address healthcare costs and improve access to high-quality care. The post PBGH Calls on New Congress and Administration to Improve Employee Healthcare in 2 Key Areas appeared first on MedCity News.

Pfizer Drug Hits Goals of Colorectal Cancer Study, Clearing Way to Seek Full FDA Approval February 3, 2025

Pfizer’s Braftovi received accelerated FDA approval in December as a first-line treatment for metastatic colorectal cancer with a particular genetic mutation. The pharma giant now says the drug has hit primary and secondary goals of its Phase 3 clinical trial. The post Pfizer Drug Hits Goals of Colorectal Cancer Study, Clearing Way to Seek Full […]

Suicide Is Contagious February 3, 2025

For every life lost, the ripple effects continue outward, often creating distinct suicide clusters, which account for as many as 5% of all suicides. Breaking this cycle is essential to preventing thousands of tragedies each year. The post Suicide Is Contagious appeared first on MedCity News.

Unlocking Success in Value-Based Care: Why Focusing on Specialized Populations is Key February 3, 2025

The shift to a VBC model represents more than an evolution in healthcare delivery – it demands a fundamental redesign of our healthcare system and the economic models to support it. The post Unlocking Success in Value-Based Care: Why Focusing on Specialized Populations is Key appeared first on MedCity News.

Metsera’s IPO Raises $275M to Show How Its Obesity Drugs Can Top Current GLP-1s February 2, 2025

Investors showed appetite for Metsera’s IPO, as shares of the clinical-stage metabolic medicines biotech popped 47% in their Nasdaq debut. Maze Therapeutics and Beta Bionics also priced IPOs; the three companies raised $636 million combined. The post Metsera’s IPO Raises $275M to Show How Its Obesity Drugs Can Top Current GLP-1s appeared first on MedCity […]